Clinical Scorecard: Hospital sewer biofilms harbor resistant E. coli
At a Glance
Category
Detail
Condition
Antibiotic resistance selection and enrichment in hospital wastewater and sewer biofilms
Key Mechanisms
Laboratory experiments implicated ciprofloxacin and cefotaxime in resistance selection; biofilms showed higher proportions of resistant E. coli than corresponding hospital wastewater samples.
Target Population
Not a patient study; the study examined wastewater, sewer biofilms, and bacterial communities at Swedish hospitals and municipal wastewater sites.
Care Setting
Environmental microbiology study of hospital sewer systems and corresponding municipal wastewater treatment systems in Sweden.
Key Highlights
Hospital wastewater selected for ciprofloxacin-resistant E. coli at all 10 sampling locations and for cefotaxime-resistant E. coli at all but one.
No statistically significant resistance selection was detected in corresponding municipal wastewater samples.
Hospital sewer biofilms had 3.11-fold and 3.48-fold higher proportions of ciprofloxacin- and cefotaxime-resistant E. coli, respectively, than corresponding hospital wastewater samples; the statistical interaction comparing enrichment patterns between hospital and municipal sites was not significant.
Experiments identified ciprofloxacin and cefotaxime as important selective agents; ciprofloxacin exposure selected resistance to all 8 antibiotics tested, and cefotaxime to 7 of 8.
The study did not establish whether resistance selected in hospital sewers contributed to infections in patients.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
No patients were enrolled or evaluated.
The study did not assess patient treatment or prescribing; it investigated antibiotic resistance selection in wastewater and sewer biofilms.
Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.
